Key facts
- Poppy Health’s last known valuation is $36.3M (Mar 2024).
- It has raised $17.5M; the latest was Later Stage VC in Mar 2025.
- Notable investors include Anthemis, Panache Ventures, Fuel Capital, Daikin Industries, F7 Ventures — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Poppy Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Poppy Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Poppy Health
Developer of a commercial pathogen sensing and detection platform designed to protect working and residential places. The company's platform helps to protect indoor spaces with a real-time system of software, data and sensors, delivered as a data-as-as service to define a new category of infection safety and building performance measurement that is used to secure occupant health, drive confidence and reduce energy costs, enabling clients to keep their areas safe from harmful pathogens.
- Sector
- Information Technology
- HQ
- Toronto, Canada
- Founded
- 2019
- Employees
- 38
- Website
- poppy.com/
- Ownership
- Privately Held (backing)
Poppy Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Poppy Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Poppy Health in its N-PORT filings yet. We sweep new filings monthly.